DB
Daniel B. Soland
Senior Vice President And Chief Operating Officer at Idera Pharmaceuticals
View Daniel's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Senior Vice President And Chief Operating Officer
Present
Company Details
1 Employees
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.
Website
Year Founded
1989
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
Durham, NC, US
Keywords
clinical development
Contact Details
- Email AddressD**@aceragen.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
You May Also Interested In
- JGDetailsJames GeibDirector, Clinical ScientistWorked together at Idera Pharmaceuticals
- MCDetailsMark CornfeldVice President Immuno-Oncology Drug DevelopmentWorked together at Idera Pharmaceuticals
- LGDetailsLindsey GranlundSenior Clinical Trial ManagerWorked together at Idera Pharmaceuticals
Find verified contacts of Daniel B. Soland in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.